Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol < 50 mg / dl with rosuvastatin - Hsia, J; MacFadyen, J G; Monyak, J (The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). J Am Coll Cardiol, 2011)
et al.